Pharming (PHAR) Net Cash Flow (2020 - 2023)
Historic Net Cash Flow for Pharming (PHAR) over the last 5 years, with Q2 2023 value amounting to -$104.9 million.
- Pharming's Net Cash Flow fell 115540.69% to -$104.9 million in Q2 2023 from the same period last year, while for Mar 2024 it was -$104.9 million, marking a year-over-year decrease of 62891630.21%. This contributed to the annual value of $77536.7 for FY2020, which is 10045.07% up from last year.
- As of Q2 2023, Pharming's Net Cash Flow stood at -$104.9 million, which was down 115540.69% from -$2.7 million recorded in Q4 2022.
- Pharming's 5-year Net Cash Flow high stood at $14.0 million for Q3 2020, and its period low was -$104.9 million during Q2 2023.
- In the last 5 years, Pharming's Net Cash Flow had a median value of -$2.7 million in 2022 and averaged -$17.1 million.
- Within the past 5 years, the most significant YoY rise in Pharming's Net Cash Flow was 16100.76% (2022), while the steepest drop was 12597143.41% (2022).
- Pharming's Net Cash Flow (Quarter) stood at -$90.6 million in 2019, then skyrocketed by 100.15% to $134280.4 in 2020, then plummeted by 108.19% to -$11003.9 in 2021, then crashed by 24027.9% to -$2.7 million in 2022, then tumbled by 3851.71% to -$104.9 million in 2023.
- Its Net Cash Flow was -$104.9 million in Q2 2023, compared to -$2.7 million in Q4 2022 and -$7.3 million in Q3 2022.